-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - Efficacy and safety of fasinumab in patients
with chronic low back pain: a phase II/III
randomised … in patients with
knee pain due to osteoarthritis: an
exploratory post hoc analysis of a Japanese
phase … or chronic low back pain with
early pain reduction: an exploratory post-
hoc analysis of Japanese phase … Open-
label phase 3 study of diclofenac conjugated
to hyaluronate (diclofenac etalhyaluronate:
ONO- … ][TM]s effect in Chinese patients with
chronic pain due to osteoarthritis: post hoc
analyses of a phase
-
effectivehealthcare.ahrq.gov/products/safety-vaccines/protocol
April 06, 2020 - 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 (152174)
("clinical trial" or "clinical trial, phase … i" or "clinical trial, phase ii" or clinical trial, phase iii or clinical trial, phase iv or controlled … randomized controlled trial").pt. or double-blind method/ or clinical trials as topic/ or clinical trials, phase … i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical … trials, phase iv as topic/ or controlled clinical trials as topic/ or randomized controlled trials as
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cultural-competence_research-protocol.pdf
July 09, 2014 - The literature set identified at this phase will be examined from a content
analysis perspective for … ii.pt.
41
clinical
trial,
phase
iii.pt.
42
clinical
trial,
phase … i.pt.
40
clinical
trial,
phase
ii.pt.
41
clinical
trial,
phase
… iii.pt.
42
clinical
trial,
phase
iv.pt.
43
controlled
clinical
trial.pt … i.pt.
40
clinical
trial,
phase
ii.pt.
41
clinical
trial,
phase
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the seven topics for which (1) preliminary phase III data on drugs or … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Three
phase III trials did not individually demonstrate statistical superiority of mifepristone over … Paul, MN) are both in phase III development for DBS for
MDD.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
July 01, 2022 - A
randomized, double-blind, placebo-
controlled phase III trial of duloxetine in
Japanese patients … Randomized, double-blind, placebo-
controlled phase III trial of duloxetine
monotherapy in Japanese … A
randomized, double-blind, placebo-
controlled phase III trial of duloxetine in
Japanese fibromyalgia … Efficacy and safety of fasinumab in patients
with chronic low back pain: a phase II/III
randomised … Open-
label phase 3 study of diclofenac conjugated
to hyaluronate (diclofenac etalhyaluronate:
ONO-
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Results
The table below lists the 17 topics for which (1) preliminary phase III data were available … In phase III trials, icatibant provided significant symptom relief within about 2
hours and initial … Placebo-
controlled phase 3 study of oral BG-12 for
relapsing multiple sclerosis. … Placebo-
controlled phase 3 study of oral BG-12 or
glatiramer in multiple sclerosis. … ThromboGenics'
microplasmin phase III program progressing
according to schedule. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - Results
The table below lists the five topics for which (1) preliminary phase III data for drugs were … Completed phase III trials did not demonstrate statistical superiority
of mifepristone over placebo … Paul, MN) are in phase III development for DBS for
treating BPD and MDD. … Reclaim/Activa trials for MDD have an anticipated completion date
of October 2014; phase III trials … III clinical
trial.9 Three completed phase III trials did not demonstrate superiority of mifepristone
-
effectivehealthcare.ahrq.gov/sites/default/files/ptsd-comments.pdf
November 04, 2020 - Since the Phase 1 work and report,
we have worked closely with the National
Center for PTSD to obtain … Since the Phase 1 work and report,
we have worked closely with the National
Center for PTSD to obtain … For this phase of development, as
recommended by the TEP and NCPTSD,
treatments were categorized according … of the PTSD-Repository and
updated in this next phase of work. … in a subsequent
article highlighting the updates to the PTSD-
Repository completed in this second phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
November 04, 2020 - Since the Phase 1 work and report,
we have worked closely with the National
Center for PTSD to obtain … Since the Phase 1 work and report,
we have worked closely with the National
Center for PTSD to obtain … For this phase of development, as
recommended by the TEP and NCPTSD,
treatments were categorized according … of the PTSD-Repository and
updated in this next phase of work. … in a subsequent
article highlighting the updates to the PTSD-
Repository completed in this second phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0086_04-01-2009.pdf
January 01, 2009 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0030_06-19-2008.pdf
January 01, 2008 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed
in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0074_03-10-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
January 01, 2008 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
January 01, 2008 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - Results
The table below lists the 12 topics for which (1) preliminary phase III data on drugs or phase … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Reclaim is in phase III trials for MDD with an anticipated
completion date of October 2014; Libra is … also in phase III trials. … Jude Medical is evaluating its Libra
®
DBS system for treatment-resistant depression in the
phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … None of these topics
emerged as eligible for inclusion in this report because preliminary phase III … These topics were ineligible for
consideration in this report because no phase III data were available
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - versus active
surveillance in men with low-risk
prostate cancer (CLIN1001 PCM301):
an open-label, phase … Patients With Low-
Risk Prostate Cancer Treated With
Hypofractionated vs Conventional
Radiotherapy: A Phase … 26 (763246)
29 27 and 28 (43063)
30 limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase
iii or clinical trial, phase iv or clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
August 01, 2022 - Phase 3 randomized, placebo-controlled,
double-blind study of lasmiditan for acute
treatment of migraine … Lasmiditan is an effective acute treatment
for migraine: a phase 3 randomized study. … Rimegepant for the acute treatment
of migraine: subgroup analyses from 3
phase 3 clinical trials by … STOP 301: A Phase 3, open-label study
of safety, tolerability, and exploratory
efficacy of INP104, … Evaluation of injection-site-related
adverse events with galcanezumab: a post
hoc analysis of phase